Cancers remain incurable, and have caused 8.2 million deaths worldwide (WHO world cancer report 2014). In 2020, The top 3 cancer types (lung, liver and stomach) are projected to cause 2 million deaths in China.
Traditional treatments – surgery, radiation and chemotherapies often result in unpleasant side effects, and demonstrate limited or marginal therapeutic benefits. Molecular targeted therapy is effective for a small patient segment (5-10%) and followed by a high disease relapse rate.
Cancer immunotherapy - Recent advances and success with immunotherapies has changed the landscape of cancer treatment strategies.
Chimeric Antigen Receptor (CAR) technology directs T and NK (natural killer) cells to recognize cancer cells based on expression of specific cell surface proteins.Learn More
The use of bispecific antibodies, targeting two tumor antigens for cancer treatment. This approach evolves to BiTE therapeutics, a bi-specific mAb that forms a link between tumor and T cells, causing cancer cell death.Learn More
Using high-throughput and cutting-edge DNA sequencing technology, we can identify the oncogenes and mutations unique in patient's samples - tumor and liquid biopsies for early diagnosis and precision treatments.Learn More